EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications ; volume:12 ; number:1 ; day:21 ; month:11 ; year:2019 ; pages:1-13 ; date:12.2019
Journal of hematology & oncology ; 12, Heft 1 (21.11.2019), 1-13, 12.2019
- Urheber
-
Li, Boheng
Chng, Wee-Joo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-019-0814-6
- URN
-
urn:nbn:de:101:1-2020031722204385923030
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Boheng
- Chng, Wee-Joo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epidemiology of lymphoid malignancies: last decade update
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Mechanisms of B-cell antigen receptor activation in lymphoid malignancies
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Epidemiology of lymphoid malignancies: last decade update
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Mechanisms of B-cell antigen receptor activation in lymphoid malignancies
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
Epidemiology of lymphoid malignancies: last decade update
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Diagnostic and prognostic molecular pathology of lymphoid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Mechanisms of B-cell antigen receptor activation in lymphoid malignancies
Pattern recognition in lymphoid malignancies using CytoGPS and Mercator
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies